Foxo Technologies Inc
FOXO1.570USD
+0.933+146.82%
Close 05/09, 16:00（ET）Quotes delayed by 15 min
36.99MMarket Cap
--P/E TTM
More Details of Foxo Technologies Inc Company
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Company Info
Company codeFOXO
Company nameFoxo Technologies Inc
IPO dateDec 11, 2020
Founded at2020
CEOMr. Seamus Lagan
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 11
Address477 South Rosemary Avenue
CityWEST PALM BEACH
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code33401
Phone16128000059
Websitehttp://delwinds.com/
Company codeFOXO
IPO dateDec 11, 2020
Founded at2020
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Fri, May 9
Update time: Fri, May 9
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Shareholder Statistics
Shareholder
Proportion
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Type
Shareholder
Proportion
Corporation
3.31%
Investment Advisor
0.64%
Research Firm
0.47%
Investment Advisor/Hedge Fund
0.46%
Hedge Fund
0.07%
Other
95.05%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
44
297.90K
11.61%
-32.78K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
2022Q4
123
1.73M
63.52%
-18.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Clearthink Capital Partners LLC
600.00K
2.55%
+600.00K
--
Dec 01, 2023
GWG Wind Down Trust
464.67K
1.97%
+464.67K
--
Aug 11, 2023
Kr8 ai Inc
237.04K
1.01%
--
--
Nov 14, 2024
UBS Financial Services, Inc.
139.89K
0.59%
+139.89K
--
Dec 31, 2024
Jane Street Capital, L.L.C.
117.05K
0.5%
+117.05K
--
Dec 31, 2024
Sabby Management, LLC
80.56K
0.34%
+80.56K
--
Dec 31, 2024
SBI Securities Co., Ltd.
39.33K
0.17%
+39.33K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
42.46K
0.18%
--
--
Dec 31, 2024
Corbin Capital Partners, L.P.
27.48K
0.12%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
27.23K
0.12%
-76.72K
-73.81%
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Date
Type
Ratio
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1